Hims & Hers Health Inc

Hims & Hers Health’s stock surged 34% on April 29, 2025, following a partnership with Novo Nordisk, but a subsequent downgrade by TD Cowen and increased options trading activity highlighted market caution.

Hims & Hers Health Inc. sees its stock surge 34% after announcing a strategic partnership with Novo Nordisk to sell Wegovy, a GLP-1 medication, marking a significant milestone in its expansion into the healthcare sector.